<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Dosage regimen and precaution of antiviral drugs in children</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Drugs</th>
    <th align="left">Age available</th>
    <th align="left">Dosage regimen of COVID-19 in children</th>
    <th align="left">Precaution/contraindication</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">IFN-α</td>
    <td align="left">Nebulization: using with caution in neonates and infants younger than 2 months</td>
    <td align="left">
     <p>Nebulization: 200,000–400,000 IU/kg or 2–4 μg/kg in 2 mL sterile water, twice daily for 5–7 days</p>
     <p>Spray: 1–2 sprays on each nostril and 8–10 sprays on the oropharynx, once every 1–2 h, 8–10 sprays/day for 5–7 days</p>
    </td>
    <td align="left">Contraindication: CrCl &lt; 50 mL/min; histories of mental illness, severe or unstable heart disease, or aplastic anemia</td>
   </tr>
   <tr>
    <td align="left">LPVr</td>
    <td align="left">
     <p>China: OS ≥ 6 months, T ≥ 2 years</p>
     <p>USA: OS ≥ 14 days, T ≥ 6 months</p>
    </td>
    <td align="left">
     <p>Body weight (kg)</p>
     <p> 7–15: 12 mg/3 mg/kg/time, twice daily for 1–2 weeks</p>
     <p> 15–40: 10 mg/2.5 mg/kg/time, twice daily for 1–2 weeks</p>
     <p> &gt; 40: 400 mg/100 mg/time, twice daily for 1–2 weeks</p>
    </td>
    <td align="left">
     <p>Contraindication: patients with severe hepatic insufficiency</p>
     <p>Not be recommended: children with jaundice</p>
    </td>
   </tr>
   <tr>
    <td align="left">Ribavirin</td>
    <td align="left">
     <p>China: oral dosage forms ≥ 6 years</p>
     <p>USA and Europe: oral dosage forms ≥ 3 years</p>
    </td>
    <td align="left">Intravenous infusion at a dose of 10 mg/kg every time (maximum 500 mg every time), 2–3 times daily</td>
    <td align="left">
     <p>Not be recommended: CrCl &lt; 50 mL/min</p>
     <p>Should be discontinued: SCr &gt; 2 mg/dL</p>
     <p>Warning: hemolytic anemia</p>
    </td>
   </tr>
   <tr>
    <td align="left">CD</td>
    <td align="left">Using with caution</td>
    <td align="left">No recommendation</td>
    <td align="left">Acute poisoning is usually fatal with a dose of 50 mg/kg</td>
   </tr>
   <tr>
    <td align="left">Arbidol</td>
    <td align="left">≥ 2 years for influenza in Russia</td>
    <td align="left">No recommendation</td>
    <td align="left">Using with caution in patients with liver dysfunction</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>IFN-α</italic> interferon-α, 
   <italic>LPVr</italic> lopinavir/ritonavir, 
   <italic>CD</italic> chloroquine diphosphate, 
   <italic>COVID-19</italic> coronavirus disease 2019, 
   <italic>CrCl</italic> creatinine clearance, 
   <italic>SCr</italic> serum creatinine, 
   <italic>OS</italic> oral solutions, 
   <italic>T</italic> tablets
  </p>
 </table-wrap-foot>
</table-wrap>
